Patients with positive rheumatoid factor (RF) and/or anticyclic citrullinated peptide (anti-CCP) and/or C-reactive protein (CRP) are known to be at increased risk of developing worse prognosis of erosive arthritis, the main clinical manifestation of which is synovitis (4). This evidence concerns the gene CRP and synovitis.